Investor Backing & Capital Strength:
Back-to-back financings — a $47M Series A (Jan 2025) followed by a $103M Series B at a $1B+ valuation (Sept 2025) — indicate ample runway to hire and expand. Coverage across major outlets reinforces that capitalization supports scaling GTM and product.
Product Line Growth:
The shift to an all‑in‑one platform with the EveOS launch and additions like AI Agents, AI Auditor, and AI Analyst shows expansion beyond point tools into a broader operating system for plaintiff firms. This broadening footprint suggests increasing ability to deepen lock‑in across intake, drafting, discovery, and auditing.
Strong Revenue Growth:
Revenue trajectory is described as rapidly rising (e.g., 5x–10x growth claims and an estimated $24.2M in 2025), aligning with the scale-up signals reported through 2025–2026. While many specifics are company-reported, the direction of growth is consistently presented as strong.
